Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice

International Journal of Molecular Sciences(2020)10.3390/ijms21249362Source: DataRank Database

Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice is a research paper published in International Journal of Molecular Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (44)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Megan Beauchemin,Celeste Bouchard,Elizabeth Bernier ORCID,Calvin Vary ORCID,Meghan May ORCID

Live enrichment

PubMed:33302598

National Institutes of Health

Grant: DK095143

National Institutes of Health

Grant: 3P20GM121301-05S1

COBRE in Mesenchymal and Neural Regulation of Metabolic Networks - Metabolic Phenotyping Equipment

National Institutes of Health

Grant: 3P30GM103392-05S1

Phase III COBRE in Vascular Biology

National Institutes of Health

Grant: 3U54GM115516-08S1

Northern New England Clinical and Translational Research Network - Equipment

goldLicense: cc-by

publisherhttps://www.mdpi.com/1422-0067/21/24/9362/pdf?version=1607651747

publisherhttps://www.mdpi.com/1422-0067/21/24/9362/pdf

repositoryhttps://doaj.org/article/343ae61215514fdebb67689295c7b697

repositoryhttps://dx.doi.org/10.3390/ijms21249362

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7763698

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAntipsychotic AgentsChemical and Drug Induced Liver Injury, ChronicLiverMaleMiceMice, Inbred C57BLNon-alcoholic Fatty Liver DiseaseOlanzapineProteomeRisperidone

MeSH Terms

AnimalsAntipsychotic AgentsChemical and Drug Induced Liver Injury, ChronicLiverMaleMiceMice, Inbred C57BLNon-alcoholic Fatty Liver DiseaseOlanzapineProteomeRisperidone

Keywords

nonalcoholic fatty liver diseaseMaleProteomeautonomic nervous systemliverRisperidoneArticleantipsychoticschizophreniaMice, Inbred C57BLMiceinflammationNon-alcoholic Fatty Liver DiseaseOlanzapineChemical and Drug Induced Liver Injury, Chronicenergy metabolismsteatosisAnimalsAntipsychotic Agents

Sustainable Development Goals

SDG 3: 3. Good health